The Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, classify objective tumor response into one of four categories (complete or partial response, ...
Jun 3, 2023
0
4
HER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refractory HER2-positive biliary tract cancer (BTC), researchers from The University of Texas MD Anderson Cancer Center ...
Jun 3, 2023
0
6
The best things in life are free. Or so the saying goes.
Jun 2, 2023
0
4
For women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progression-free survival, according to a study ...
Jun 2, 2023
0
5
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a progression-free survival rate of 24% and an overall survival rate of 83%. Receiving a ...
Jun 1, 2023
0
17
Smoke from more than 200 wildfires burning across Canada has been turning skies hazy in North American cities far from the flames.
May 23, 2023
0
21
Turmeric has been used by humans for more than 4,000 years. As well as cooking and cosmetics, it's been a staple of the traditional medicine practice of Ayurveda, used to treat a variety of conditions from arthritis to wind.
May 23, 2023
0
51
Sarcopenia is the progressive and accelerated loss of muscle mass and strength as we age.
May 17, 2023
0
34
It's estimated celiac disease affects 1.4% of the world's population—a staggering 112,000,000 people or so in total.
May 16, 2023
0
1
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research led by an oncologist from Dana-Farber Cancer ...
May 10, 2023
0
40
